TP53 and glioblastoma: The clinical relevance of these findings is reflected by our demonstration through genome wide transcriptional motif analyses in a large number of GBM patients that GBMs with high levels of JMJD3 expression and wildtype TP53 show significantly enhanced p53 pathway activation.